Voices of Oncology

Fostering a Collaborative Community of Experts to Accelerate Cancer Cures

Häftad, Engelska, 2025

349 kr

Beställningsvara. Skickas inom 3-6 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Voices of Oncology is a groundbreaking exploration of the evolving landscape in cancer treatment development. Beyond scientific advancements, the field is being reshaped by societal and cultural forces that are redefining what it takes to bring new therapies to patients.Through exclusive interviews with leading experts from across oncology, this book captures the complexity of a multidisciplinary approach. Each chapter highlights the challenges and breakthroughs that arise from collaboration between pharmaceutical leaders, academic researchers, patient advocates, and healthcare innovators. Together, these voices underscore a powerful message: only by breaking down silos and sharing insights can we accelerate progress and ultimately, conquer cancer.To go beyond the book and be a voice in a dynamic collaboration of stakeholders in oncology today, we invite you to join the Oncology Voice Network (OVN), an online community for those committed to transforming oncology through shared knowledge and collective action.

Produktinformation

Utgivningsdatum2025-10-23
Mått152 x 229 x 43 mm
Vikt816 g
FormatHäftad
SpråkEngelska
Antal sidor496
FörlagAdvantage Media Group
ISBN9798887500669

Tillhör följande kategorier

Onkologi inom Medicin
Medicinsk utrustning och medicinska tekniker inom Medicin
Farmakologi inom Medicin

Dr. KIRK SHEPARD , a board-certified oncologist and hematologist, has led pharmaceutical innovation for over thirty years, including roles at Boehringer Ingelheim, Takeda, and Eisai. Currently CMO at PDS Biotechnology, his expertise spans all phases of drug development and commercialization. In 2015, PharmaVoice named him among the 100 Most Inspiring People in Pharma. He also cofounded the Medical Affairs Professional Society (MAPS) and co-edited Medical Affairs (2024).Dr. RAMIN FARHOOD, senior VP at SSI Strategy, has over twenty-five years in patient-centric medical strategy. Previously at Novartis, he launched the world’s first gene therapy for spinal muscular atrophy. Farhood cofounded the Medical Affairs Professional Society (MAPS) and the Immunoglobulin National Society (IgNS) and cohosts The Emerging Biotech Leader podcast.

ForewordIntroduction: Increased Understanding = Increased CollaborationVoice of Academic Clinical InvestigationVoice of Executive LeadershipVoice of Chemistry, Manufacturing, and Controls (CMC)Voice of Clinical DevelopmentVoice of CommercialVoice of ComplianceVoice of Health Economics and Outcomes Research and Real-World EvidenceVoice of Innovation PartnersVoice of Market AccessVoice of Medical AffairsVoice of Field MedicalVoice of National Comprehensive Cancer Network (NCCN)Voice of the PatientVoice of Patient AdvocacyVoice of Preclinical ResearchVoice of Regulatory AffairsVoice of SafetyVoice of Scientific CommunicationsVoice of Statistics in Clinical Research/BiostatisticsVoice of Talent and Workforce InnovationVoice of Digital and TechnologyConclusion: A Global Hub for Collaboration and ProgressGlossary